Interfering with chemokine networks — the hope for new therapeutics
- 1 August 1999
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 3 (4) , 407-417
- https://doi.org/10.1016/s1367-5931(99)80061-1
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tractNature, 1998
- Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4The Journal of Experimental Medicine, 1997
- Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue EosinophiliaThe Journal of Experimental Medicine, 1997
- Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors.Journal of Clinical Investigation, 1996
- Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1Nature, 1996
- Activation of Dual T Cell Signaling Pathways by the Chemokine RANTESScience, 1995
- Requirement of Mip-1α for an Inflammatory Response to Viral InfectionScience, 1995
- Cloning of Complementary DNA Encoding a Functional Human Interleukin-8 ReceptorScience, 1991
- Structure and Functional Expression of a Human Interleukin-8 ReceptorScience, 1991
- Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTESNature, 1990